The gene array market is experiencing steady growth, projected at a 1.5% CAGR from 2025-2033, reaching $903.6 million in 2025. Driven by genomics research and personalized medicine, this market is segmented by chip type (oligonucleotide, cDNA) and application (gene expression, genotyping, etc.). Key players include Illumina, Affymetrix, and Agilent. Learn more about market trends and projections.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
